FibroGen, Inc. (FGEN)
USD 0.28
(-4.72%)
USD 0.28
(-4.72%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 585.72 Million USD | -4.23% |
| 2022 | 611.56 Million USD | 12.27% |
| 2021 | 544.7 Million USD | 41.34% |
| 2020 | 385.39 Million USD | 19.69% |
| 2019 | 321.99 Million USD | -8.56% |
| 2018 | 352.12 Million USD | 11.36% |
| 2017 | 316.2 Million USD | 7.39% |
| 2016 | 294.44 Million USD | 7.56% |
| 2015 | 273.74 Million USD | 12.72% |
| 2014 | 242.85 Million USD | 28.26% |
| 2013 | 189.34 Million USD | 32.04% |
| 2012 | 143.4 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 552.02 Million USD | -5.75% |
| 2024 Q2 | 483.57 Million USD | -12.4% |
| 2023 Q3 | 575.62 Million USD | 0.03% |
| 2023 FY | 585.72 Million USD | -4.23% |
| 2023 Q1 | 567.42 Million USD | -7.22% |
| 2023 Q4 | 585.72 Million USD | 1.75% |
| 2023 Q2 | 575.43 Million USD | 1.41% |
| 2022 Q2 | 563.04 Million USD | -0.86% |
| 2022 Q1 | 567.91 Million USD | 4.26% |
| 2022 Q3 | 562.56 Million USD | -0.08% |
| 2022 Q4 | 611.56 Million USD | 8.71% |
| 2022 FY | 611.56 Million USD | 12.27% |
| 2021 FY | 544.7 Million USD | 41.34% |
| 2021 Q1 | 397.02 Million USD | 3.02% |
| 2021 Q4 | 544.7 Million USD | 7.77% |
| 2021 Q3 | 505.45 Million USD | -4.41% |
| 2021 Q2 | 528.76 Million USD | 33.18% |
| 2020 Q2 | 392.54 Million USD | 13.21% |
| 2020 Q4 | 385.39 Million USD | 12.99% |
| 2020 FY | 385.39 Million USD | 19.69% |
| 2020 Q1 | 346.74 Million USD | 7.69% |
| 2020 Q3 | 341.08 Million USD | -13.11% |
| 2019 Q4 | 321.99 Million USD | 14.9% |
| 2019 Q2 | 266.76 Million USD | -12.22% |
| 2019 Q1 | 303.9 Million USD | -13.7% |
| 2019 FY | 321.99 Million USD | -8.56% |
| 2019 Q3 | 280.24 Million USD | 5.05% |
| 2018 Q2 | 355.11 Million USD | 1.8% |
| 2018 Q3 | 365.05 Million USD | 2.8% |
| 2018 Q4 | 352.12 Million USD | -3.54% |
| 2018 FY | 352.12 Million USD | 11.36% |
| 2018 Q1 | 348.82 Million USD | 10.32% |
| 2017 Q3 | 304.12 Million USD | 3.7% |
| 2017 FY | 316.2 Million USD | 7.39% |
| 2017 Q4 | 316.2 Million USD | 3.97% |
| 2017 Q2 | 293.26 Million USD | 0.85% |
| 2017 Q1 | 290.78 Million USD | -1.24% |
| 2016 Q2 | 286.75 Million USD | 7.68% |
| 2016 Q1 | 266.31 Million USD | -2.72% |
| 2016 Q3 | 288.59 Million USD | 0.64% |
| 2016 FY | 294.44 Million USD | 7.56% |
| 2016 Q4 | 294.44 Million USD | 2.03% |
| 2015 FY | 273.74 Million USD | 12.72% |
| 2015 Q3 | 262.69 Million USD | -2.17% |
| 2015 Q2 | 268.5 Million USD | 15.91% |
| 2015 Q1 | 231.65 Million USD | -4.61% |
| 2015 Q4 | 273.74 Million USD | 4.21% |
| 2014 Q3 | 234.73 Million USD | 0.83% |
| 2014 Q2 | 232.79 Million USD | 21.94% |
| 2014 Q1 | 190.91 Million USD | 0.83% |
| 2014 Q4 | 242.85 Million USD | 3.46% |
| 2014 FY | 242.85 Million USD | 28.26% |
| 2013 Q4 | 189.34 Million USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 189.34 Million USD | 32.04% |
| 2012 FY | 143.4 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -74.44% |
| Alkermes plc | 933.53 Million USD | 37.257% |
| Agenus Inc. | 462.29 Million USD | -26.7% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 85.539% |
| Aptorum Group Limited | 5.25 Million USD | -11042.423% |
| Ardelyx, Inc. | 130.76 Million USD | -347.931% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -22.437% |
| Bicycle Therapeutics plc | 224.41 Million USD | -161.006% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -349.833% |
| ChromaDex Corporation | 26.5 Million USD | -2109.627% |
| Chimerix, Inc. | 19.74 Million USD | -2866.462% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1565.083% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -707.155% |
| CRISPR Therapeutics AG | 346.76 Million USD | -68.911% |
| Precision BioSciences, Inc. | 140.92 Million USD | -315.646% |
| Dyadic International, Inc. | 2.34 Million USD | -24924.149% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -3501.599% |
| Fortress Biotech, Inc. | 165.93 Million USD | -252.978% |
| Lantern Pharma Inc. | 2.73 Million USD | -21279.416% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -719.429% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -16498.857% |
| Incyte Corporation | 1.59 Billion USD | 63.214% |
| IO Biotech, Inc. | 17.55 Million USD | -3236.341% |
| Jaguar Health, Inc. | 45.86 Million USD | -1177.042% |
| Novavax, Inc. | 2.57 Billion USD | 77.229% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1524.405% |
| Opthea Limited | 264.6 Million USD | -121.362% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -348.123% |
| ContextLogic Inc. | 206 Million USD | -184.334% |
| MiMedx Group, Inc. | 96.33 Million USD | -508.043% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1119.708% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -16498.095% |
| NextCure, Inc. | 14.99 Million USD | -3805.634% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -14391.044% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -8672.323% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1153.189% |
| Vaxcyte, Inc. | 167.44 Million USD | -249.795% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1661.104% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -149.019% |
| Pharming Group N.V. | 244.07 Million USD | -139.981% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -4813.001% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -358.348% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -8764.89% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -8764.89% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -610.55% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -8717.221% |
| Acelyrin, Inc. | 86.35 Million USD | -578.295% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -44982.321% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -3973.496% |
| Summit Therapeutics Inc. | 125.25 Million USD | -367.621% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -6079.217% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1014.166% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -751.634% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -286.589% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -29845.194% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -43756.229% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -158.221% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -6153.101% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -157.525% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -18.446% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -5266.758% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2029.068% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -4738.848% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -20.371% |
| Immix Biopharma, Inc. | 3.72 Million USD | -15637.833% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1449.053% |
| MEI Pharma, Inc. | 8.35 Million USD | -6910.509% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1918.708% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -68.516% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -301.544% |
| Fortress Biotech, Inc. | 165.93 Million USD | -252.978% |
| Precigen, Inc. | 41.64 Million USD | -1306.512% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1073.098% |
| AlloVir, Inc. | 45.01 Million USD | -1201.184% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -349.395% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -325.057% |
| ImmuCell Corporation | 18.81 Million USD | -3013.086% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1975.136% |
| Onconetix, Inc. | 23.18 Million USD | -2426.771% |
| PureTech Health plc | 125.58 Million USD | -366.407% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -6444.447% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1608.558% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -23856.155% |
| Seer, Inc. | 39.36 Million USD | -1387.941% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -847.259% |
| Innoviva, Inc. | 568.55 Million USD | -3.021% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2051.197% |
| ESSA Pharma Inc. | 3.49 Million USD | -16658.687% |
| GlycoMimetics, Inc. | 6.9 Million USD | -8386.261% |
| GT Biopharma, Inc. | 6.63 Million USD | -8730.514% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -121.539% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -115.114% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -597.079% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -5892.715% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2055.869% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -18057.756% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -694.024% |
| Aptose Biosciences Inc. | 15.8 Million USD | -3605.099% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -5205.658% |
| Soligenix, Inc. | 7.27 Million USD | -7951.35% |
| Century Therapeutics, Inc. | 175.94 Million USD | -232.912% |
| Kura Oncology, Inc. | 51.66 Million USD | -1033.77% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -382.947% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -14071.982% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -8756.076% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -131.881% |
| Autolus Therapeutics plc | 263.9 Million USD | -121.945% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -5487.941% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -559.151% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1148.914% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -65.996% |
| GRI Bio, Inc. | 2.69 Million USD | -21617.76% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -72249.167% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1783.915% |
| IGM Biosciences, Inc. | 220.17 Million USD | -166.026% |
| INmune Bio, Inc. | 18.86 Million USD | -3005.333% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -128.373% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2098.529% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -21446.745% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -17756.113% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -902.015% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -509.124% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -121.251% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 28.833% |
| Verastem, Inc. | 71.18 Million USD | -722.825% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1091.085% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1418.295% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1097.024% |
| Histogen Inc. | 5.69 Million USD | -10181.341% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -13255.694% |
| Surrozen, Inc. | 8.14 Million USD | -7091.258% |
| Organovo Holdings, Inc. | 2.74 Million USD | -21214.702% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -186521.976% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -941.667% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -3447.287% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1046.171% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -70736.342% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -362.204% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -5316.592% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -288.185% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -22364.538% |
| Apollomics, Inc. | 14.15 Million USD | -4038.543% |
| Amarin Corporation plc | 279.58 Million USD | -109.498% |
| Mesoblast Limited | 188.79 Million USD | -210.241% |
| Turnstone Biologics Corp. | 14.14 Million USD | -4040.006% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -223.986% |
| Synaptogenix, Inc. | 5.52 Million USD | -10492.844% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -8710.59% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -244.327% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -6744.861% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -33229.369% |
| Exelixis, Inc. | 678.44 Million USD | 13.666% |
| Better Therapeutics, Inc. | 23.84 Million USD | -2356.707% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -257.051% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 1.427% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5384.24% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -35975.525% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1404.683% |
| Gritstone bio, Inc. | 125.91 Million USD | -365.163% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3891.06% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -11410.531% |
| Avid Bioservices, Inc. | 275.66 Million USD | -112.476% |
| Insmed Incorporated | 1.66 Billion USD | 64.753% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -7512.765% |
| MediWound Ltd. | 27.18 Million USD | -2054.441% |
| OmniAb, Inc. | 87.4 Million USD | -570.169% |
| Alector, Inc. | 487.66 Million USD | -20.108% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -45.178% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -3078.985% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1426.407% |
| Zai Lab Limited | 240.17 Million USD | -143.873% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 7.036% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1904.065% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -516.056% |
| Immunic, Inc. | 25.36 Million USD | -2208.925% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -745.988% |
| Veracyte, Inc. | 93.71 Million USD | -524.983% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -22284.455% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3269.545% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -89587.571% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -10256.862% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 92.35% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -7044.767% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -597.113% |
| TG Therapeutics, Inc. | 169.08 Million USD | -246.41% |
| Galecto, Inc. | 5.89 Million USD | -9834.328% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -6970.594% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 77.63% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1932.225% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -4540.9% |
| XBiotech Inc. | 8.39 Million USD | -6875.444% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3891.06% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1001.407% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -61.31% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2078.723% |
| Theravance Biopharma, Inc. | 169 Million USD | -246.576% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 51.816% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -17.046% |
| Vaxxinity, Inc. | 30.94 Million USD | -1792.865% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 39.77% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -9611.783% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 21.403% |
| NexImmune, Inc. | 5.08 Million USD | -11420.481% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -157610.679% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -18949.007% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 91.759% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -11264.466% |
| Scopus BioPharma Inc. | 7.45 Million USD | -7757.444% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2127.611% |
| Ainos, Inc. | 7.39 Million USD | -7821.427% |
| Pluri Inc. | 34.11 Million USD | -1617.073% |
| Prothena Corporation plc | 135.01 Million USD | -333.818% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -140.938% |
| Celularity Inc. | 102.92 Million USD | -469.06% |
| Rallybio Corporation | 9.43 Million USD | -6107.376% |
| Cue Biopharma, Inc. | 24.44 Million USD | -2296.106% |
| MeiraGTx Holdings plc | 319.99 Million USD | -83.045% |
| Omeros Corporation | 403.25 Million USD | -45.251% |
| Humacyte, Inc. | 114.67 Million USD | -410.763% |
| Immunocore Holdings plc | 228.15 Million USD | -156.72% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -11914.933% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -663.263% |
| Blueprint Medicines Corporation | 918.64 Million USD | 36.24% |
| CalciMedica, Inc. | 4.02 Million USD | -14441.41% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -3256.223% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -279.99% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -582.531% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -110.851% |
| Pulmatrix, Inc. | 15.96 Million USD | -3569.285% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -3613.485% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -2280.428% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -133.536% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1053.325% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 51.618% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1742.897% |
| Nutriband Inc. | 1.07 Million USD | -54188.413% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -5408.586% |
| Vor Biopharma Inc. | 59.1 Million USD | -891.012% |
| Roivant Sciences Ltd. | 773.95 Million USD | 24.32% |
| Evogene Ltd. | 17.99 Million USD | -3155.853% |
| ProKidney Corp. | 29.21 Million USD | -1904.819% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -713.748% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -82983.989% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 68.991% |
| CorMedix Inc. | 11.91 Million USD | -4814.845% |
| BioLineRx Ltd. | 50.7 Million USD | -1055.236% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -291.899% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -562.281% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1091.424% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1780.208% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -3160.929% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -369.951% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -10259.533% |
| MediciNova, Inc. | 3.89 Million USD | -14951.266% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -3104.377% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -38838.441% |
| GeoVax Labs, Inc. | 3.51 Million USD | -16540.563% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -47.442% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1808.53% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 78.48% |
| Mereo BioPharma Group plc | 15.96 Million USD | -3569.515% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1777.273% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -898.105% |
| Absci Corporation | 58.3 Million USD | -904.61% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2975.01% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1726.861% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -693.777% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -569.534% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1634.463% |
| Allakos Inc. | 74.79 Million USD | -683.132% |
| Imunon, Inc. | 8.53 Million USD | -6766.339% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2503.12% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -410.163% |
| BioAtla, Inc. | 48.98 Million USD | -1095.705% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5384.24% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -20976.934% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -348.476% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -4020.492% |
| XOMA Corporation | 145.58 Million USD | -302.341% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1639.872% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -751.856% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1753.746% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -847.427% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1202.631% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1110.132% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -20308.641% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -7079.783% |
| Akari Therapeutics, Plc | 4.58 Million USD | -12677.661% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3203.015% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 64.49% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -144915.201% |
| UroGen Pharma Ltd. | 243.52 Million USD | -140.523% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -82.42% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -21110.056% |
| Orgenesis Inc. | 35.53 Million USD | -1548.313% |
| Entera Bio Ltd. | 1.37 Million USD | -42374.837% |
| GH Research PLC | 6.7 Million USD | -8640.904% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -8513.647% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -3011.272% |
| Xencor, Inc. | 283.55 Million USD | -106.563% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -19517.942% |
| Replimune Group, Inc. | 113.21 Million USD | -417.364% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -15489.793% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -465.757% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -144915.201% |
| Portage Biotech Inc. | 4.45 Million USD | -13062.427% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -38838.441% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2441.119% |
| OncoCyte Corporation | 49.29 Million USD | -1088.137% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -14058.946% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -73346.991% |
| Purple Biotech Ltd. | 10 Million USD | -5754.353% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -10023.194% |
| scPharmaceuticals Inc. | 57.26 Million USD | -922.909% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -4628.181% |
| HilleVax, Inc. | 78.9 Million USD | -642.283% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -11498.574% |
| Tharimmune, Inc. | 1.81 Million USD | -32170.697% |
| Genprex, Inc. | 3.25 Million USD | -17899.095% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2059.844% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -11086.555% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -284233.981% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -163261.112% |
| OKYO Pharma Limited | 7.42 Million USD | -7793.008% |
| Savara Inc. | 37.19 Million USD | -1474.876% |
| Curis, Inc. | 57.61 Million USD | -916.677% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2124.577% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1394.212% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -40462.881% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2713.43% |
| BeiGene, Ltd. | 2.23 Billion USD | 73.778% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2651.214% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -123.222% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2653.257% |
| Erasca, Inc. | 78.61 Million USD | -645.097% |
| bluebird bio, Inc. | 424.62 Million USD | -37.94% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -89289.731% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 69.01% |
| DBV Technologies S.A. | 42.8 Million USD | -1268.523% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -89289.731% |
| Moderna, Inc. | 4.57 Billion USD | 87.189% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -8273.524% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -35270.048% |
| Molecular Templates, Inc. | 31.17 Million USD | -1779.08% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -3331.33% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 0.404% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -370.445% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2034.811% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1506.671% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -952.805% |
| MacroGenics, Inc. | 154.2 Million USD | -279.832% |
| RenovoRx, Inc. | 4.46 Million USD | -13015.271% |
| Adicet Bio, Inc. | 37.12 Million USD | -1477.931% |
| Prime Medicine, Inc. | 60.78 Million USD | -863.685% |
| Aditxt, Inc. | 28.53 Million USD | -1952.913% |
| Adagene Inc. | 45.16 Million USD | -1196.738% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -324042.091% |
| Quantum-Si incorporated | 26.63 Million USD | -2099.422% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 16.033% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -19151.929% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -409.501% |
| SciSparc Ltd. | 1.59 Million USD | -36622.759% |
| Vericel Corporation | 127.7 Million USD | -358.657% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -10425.412% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -586.201% |
| Generation Bio Co. | 171.63 Million USD | -241.274% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -4971.238% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1300.225% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -131.79% |
| Invivyd, Inc. | 51.71 Million USD | -1032.651% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -536.82% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -8903.926% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -675.84% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -57268.071% |
| 2seventy bio, Inc. | 310.12 Million USD | -88.868% |
| ADMA Biologics, Inc. | 193.97 Million USD | -201.959% |
| Clene Inc. | 38.95 Million USD | -1403.756% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1521.04% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -127.931% |
| GeoVax Labs, Inc. | 3.51 Million USD | -16540.563% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -207.852% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -4709.066% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -195.342% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -4703.096% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1117.451% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1008.473% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -58.367% |
| Evaxion Biotech A/S | 17.61 Million USD | -3224.698% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -263.967% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -282.364% |
| Trevena, Inc. | 48.26 Million USD | -1113.642% |
| Surrozen, Inc. | 8.14 Million USD | -7091.258% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2612.332% |
| Cingulate Inc. | 10.36 Million USD | -5553.273% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -21199.2% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1470.653% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -16231.374% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -4354.205% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -84.655% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -2257.149% |
| Clearmind Medicine Inc. | 3.61 Million USD | -16125.116% |
| Kronos Bio, Inc. | 54.2 Million USD | -980.659% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1145.091% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2473.528% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -2818.28% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2482.979% |
| ImmunityBio, Inc. | 1.09 Billion USD | 46.283% |
| Korro Bio, Inc. | 51.75 Million USD | -1031.798% |
| Kineta, Inc. | 7.22 Million USD | -8010.33% |
| BioVie Inc. | 9.7 Million USD | -5937.107% |
| Codexis, Inc. | 49.94 Million USD | -1072.723% |
| Celularity Inc. | 102.92 Million USD | -469.06% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -508.568% |
| Celcuity Inc. | 51.45 Million USD | -1038.44% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -169580.817% |
| Cibus, Inc. | 206.11 Million USD | -184.173% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1278.995% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -2123.805% |
| IN8bio, Inc. | 8.77 Million USD | -6577.246% |
| Kodiak Sciences Inc. | 213.59 Million USD | -174.229% |
| Annexon, Inc. | 47.11 Million USD | -1143.109% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -554.145% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -507.778% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -4178.822% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 77.501% |
| Eyenovia, Inc. | 19.78 Million USD | -2861.171% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -230.759% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -7525.674% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -2330.507% |
| Arcellx, Inc. | 339.75 Million USD | -72.399% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -4822.911% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -138.547% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -6024.94% |
| Moolec Science SA | 13.94 Million USD | -4100.165% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1257.36% |
| Geron Corporation | 146.12 Million USD | -300.835% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1059.123% |
| Royalty Pharma plc | 6.29 Billion USD | 90.699% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1372.566% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -198852.467% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -23707.352% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -209.653% |
| Humacyte, Inc. | 114.67 Million USD | -410.763% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1916.206% |
| 89bio, Inc. | 59.96 Million USD | -876.816% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2113.385% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -48873.913% |
| Genelux Corporation | 8.42 Million USD | -6856.39% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -8443.291% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -329.675% |
| Notable Labs, Ltd. | 4.42 Million USD | -13130.811% |
| Liquidia Corporation | 73.13 Million USD | -700.853% |
| Mustang Bio, Inc. | 17.61 Million USD | -3224.411% |
| Immunovant, Inc. | 48.95 Million USD | -1096.462% |
| Quantum-Si incorporated | 26.63 Million USD | -2099.422% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1426.009% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -18776.184% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -693.014% |
| Acasti Pharma Inc. | 11.55 Million USD | -4968.166% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2490.831% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -21446.745% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1488.329% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -42878.423% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -9508.399% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -2258.478% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2426.432% |
| PepGen Inc. | 34.63 Million USD | -1591.34% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -4723.188% |
| United Therapeutics Corporation | 1.18 Billion USD | 50.454% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -8286.712% |
| Solid Biosciences Inc. | 38.45 Million USD | -1423.033% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -6744.861% |
| Immuneering Corporation | 12 Million USD | -4777.671% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -186521.976% |
| Silo Pharma, Inc. | 1.56 Million USD | -37224.871% |
| Belite Bio, Inc | 4.21 Million USD | -13809.475% |
| XOMA Corporation | 145.58 Million USD | -302.341% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -24023.888% |
| Bionomics Limited | 10.15 Million USD | -5665.765% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2625.457% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2456.313% |
| uniQure N.V. | 624.01 Million USD | 6.136% |
| Cassava Sciences, Inc. | 14.19 Million USD | -4026.298% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -324042.091% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -244.173% |
| Forte Biosciences, Inc. | 3.66 Million USD | -15877.305% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -224675.983% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -8581.31% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -7525.674% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3269.545% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -5442.468% |
| Altimmune, Inc. | 16.54 Million USD | -3441.068% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 5.177% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2456.313% |
| Compugen Ltd. | 55.77 Million USD | -950.162% |
| Peak Bio, Inc. | 20.75 Million USD | -2722.328% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -430.248% |
| Benitec Biopharma Inc. | 4.96 Million USD | -11704.272% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -271.083% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -679.163% |
| Zura Bio Limited | 21.29 Million USD | -2650.93% |
| PolyPid Ltd. | 17.46 Million USD | -3253.149% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -421.115% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -679.163% |
| Instil Bio, Inc. | 99.8 Million USD | -486.896% |
| argenx SE | 444.95 Million USD | -31.639% |
| Immunome, Inc. | 28.65 Million USD | -1943.855% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -6925.645% |
| Verona Pharma plc | 58.84 Million USD | -895.442% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -3947.039% |
| Shattuck Labs, Inc. | 14.85 Million USD | -3841.907% |
| CervoMed Inc. | 2.59 Million USD | -22464.911% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -11917.398% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -4498.995% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -5459.829% |
| Moolec Science SA | 13.94 Million USD | -4100.165% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -24893.685% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -953.557% |
| AnaptysBio, Inc. | 364.28 Million USD | -60.788% |
| Design Therapeutics, Inc. | 11.95 Million USD | -4799.03% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -4517.849% |
| NeurAxis, Inc. | 1.91 Million USD | -30522.474% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1404.644% |
| Lumos Pharma, Inc. | 13.33 Million USD | -4293.07% |
| Achilles Therapeutics plc | 19.08 Million USD | -2968.727% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -3947.039% |
| 180 Life Sciences Corp. | 5.38 Million USD | -10772.569% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2383.162% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2473.528% |
| Nutriband Inc. | 1.07 Million USD | -54188.413% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1814.269% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -3936.441% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -45.967% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1703.738% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -4388.648% |
| Palisade Bio, Inc. | 2.73 Million USD | -21284.739% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -11050.352% |
| Beam Therapeutics Inc. | 478.38 Million USD | -22.439% |
| Neurogene Inc. | 36.54 Million USD | -1502.583% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -47.186% |
| AEON Biopharma, Inc. | 159.88 Million USD | -266.334% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1129.23% |
| Sesen Bio, Inc. | 30.98 Million USD | -1790.421% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2156.184% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -7604.701% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -199.241% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -204.976% |
| Athira Pharma, Inc. | 30.05 Million USD | -1848.724% |
| Vaccinex, Inc. | 5.94 Million USD | -9757.422% |
| HCW Biologics Inc. | 15.05 Million USD | -3791.378% |
| XOMA Corporation | 145.58 Million USD | -302.341% |
| Nektar Therapeutics | 267.04 Million USD | -119.336% |
| Arvinas, Inc. | 644.6 Million USD | 9.133% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3203.015% |
| Merus N.V. | 102.15 Million USD | -473.394% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -300.224% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -515.778% |
| Rezolute, Inc. | 11.73 Million USD | -4891.716% |
| Clene Inc. | 38.95 Million USD | -1403.756% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -20470.77% |
| BeyondSpring Inc. | 48.26 Million USD | -1113.466% |
| Synlogic, Inc. | 32.89 Million USD | -1680.599% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -3908.267% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -35746.267% |
| Peak Bio, Inc. | 20.75 Million USD | -2722.328% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -823.002% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1374.865% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -55.512% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -488.263% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -135257.709% |
| MannKind Corporation | 721.36 Million USD | 18.803% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2522.467% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -27979.003% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -470.941% |
| Gossamer Bio, Inc. | 249.14 Million USD | -135.093% |
| CohBar, Inc. | 1.03 Million USD | -56566.647% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -5379.727% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2975.01% |
| Legend Biotech Corporation | 589.93 Million USD | 0.713% |
| Mural Oncology plc | 37.92 Million USD | -1444.316% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -341.606% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -25418.226% |
| Disc Medicine, Inc. | 22.87 Million USD | -2460.56% |
| Champions Oncology, Inc. | 28.03 Million USD | -1989.274% |
| REGENXBIO Inc. | 262.22 Million USD | -123.366% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -17335.744% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -4573.113% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -4260.812% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2662.216% |
| Vaxart, Inc. | 34.02 Million USD | -1621.464% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2772.728% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1952.89% |
| Cellectis S.A. | 249.57 Million USD | -134.69% |
| Longeveron Inc. | 5.33 Million USD | -10874.855% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1300.627% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 75.648% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -870.262% |
| Revolution Medicines, Inc. | 262.39 Million USD | -123.222% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -27699.146% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -6690.262% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -4863.376% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -4070.961% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -27130.497% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 88.626% |
| Denali Therapeutics Inc. | 122.96 Million USD | -376.345% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -10425.412% |
| Veru Inc. | 32.81 Million USD | -1685.065% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -8427.122% |
| Cingulate Inc. | 10.36 Million USD | -5553.273% |
| Passage Bio, Inc. | 39.26 Million USD | -1391.845% |
| Context Therapeutics Inc. | 4.19 Million USD | -13873.469% |
| Exicure, Inc. | 8.54 Million USD | -6751.421% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1884.98% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -5485.81% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2557.447% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -259.373% |
| Nuvalent, Inc. | 31.82 Million USD | -1740.581% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -9107.204% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -829.402% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -3154.044% |
| OmniAb, Inc. | 87.4 Million USD | -570.169% |
| Anew Medical, Inc. | 8.24 Million USD | -7006.798% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1429.752% |
| Lipocine Inc. | 2.63 Million USD | -22157.241% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2129.476% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1356.6% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2098.529% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -579.862% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -10744.807% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -607.854% |
| Ocugen, Inc. | 23.98 Million USD | -2342.263% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1162.154% |
| Q32 Bio Inc. | 233.12 Million USD | -151.247% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -6360.71% |
| Alumis Inc. Common Stock | 53.5 Million USD | -994.778% |
| Equillium, Inc. | 27.95 Million USD | -1995.103% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -183.519% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -10309.861% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -9450.482% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -272.302% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -743.587% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -5772.43% |
| Dominari Holdings Inc. | 4.63 Million USD | -12537.066% |
| Edesa Biotech, Inc. | 1.84 Million USD | -31704.748% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1881.019% |
| Bio-Techne Corporation | 744.34 Million USD | 21.309% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -364.499% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -70.044% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1343.569% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1922.751% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -534.179% |
| Nkarta, Inc. | 105.6 Million USD | -454.667% |
| BioCardia, Inc. | 4.59 Million USD | -12660.959% |
| Iterum Therapeutics plc | 32.66 Million USD | -1693.301% |